Zynerba Pharmaceuticals has been acquired by Harmony Biosciences, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases. For more information on Harmony and the acquisition, please click here
The RECONNECT Trial will continue uninterrupted with Harmony Biosciences.